Bright Minds Biosciences (DRUG) Tax Provisions (2025)

Bright Minds Biosciences (DRUG) posted Tax Provisions of -$187376.6 for Q3 2025, down 200.68% on a QoQ basis from $186107.3 in Q2 2025.

Bright Minds Biosciences (DRUG) Tax Provisions (2025) Analysis & Trends

Bright Minds Biosciences' Tax Provisions history runs 1 years deep, the most recent figure standing at -$187376.6 for Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 125,146.46
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -859,000.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 31.86 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 221.50 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 104.00 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -60.00 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Bright Minds Biosciences 681.98 Mn 681.98 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 -187,376.64
Jun 30, 2025 186,107.28